% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Bartels:283051,
author = {Bartels, Frederik and Tapuc, Andreea and Rentzsch, Kristin
and Duong, Sophie L and Prüss, Harald and Finke, Carsten},
title = {{M}emory {D}eficits in {C}ancer {P}atients {W}ith {S}erum
{NMDA} {R}eceptor {A}utoantibodies.},
journal = {Neurology},
volume = {106},
number = {2},
issn = {0028-3878},
address = {Philadelphia, Pa.},
publisher = {Wolters Kluwer},
reportid = {DZNE-2025-01458},
pages = {e214490},
year = {2026},
abstract = {Neuronal autoantibodies are linked to cognitive impairment
in neurologic diseases and can be associated with tumors. In
patients with cancer, IgA/IgM N-Methyl-D-Aspartate receptor
(NMDAR) autoantibodies are most common, yet their clinical
relevance is unclear. We assessed cognitive function in
cancer patients with serum NMDAR autoantibodies and compared
the results with matched controls.For this cross-sectional
case-control study in Germany, we recruited 1,055 patients
with cancer and tested for neuronal serum autoantibodies.
Cognitive assessment was performed blinded to antibody
status and after excluding patients with potential
confounders of cognitive dysfunction. The tests included
verbal memory (Rey Auditory Verbal Learning Test),
visuospatial memory (Rey-Osterrieth Complex Figure), and
working memory.Fifty-six patients with IgA/IgM NMDAR
autoantibodies (median age 61.0 years [28.0-86.0], $35.7\%$
female) were matched 1:1 to autoantibody-negative patients
by age, sex, cancer type, and stage. Autoantibody-positive
patients showed impairments in verbal memory (mean score ±
SD: 9.7 ± 3.6 vs 11.4 ± 3.2; p = 0.01; Cohen d = 0.49),
visuospatial memory (19.4 ± 7.0 vs 22.6 ± 5.6; p = 0.01; d
= 0.50), and working memory (6.2 ± 1.9 vs 7.0 ± 2.1; p =
0.04; d = 0.40). Memory function decreased with increasing
IgA NMDAR autoantibody levels. Both groups performed
similarly on measures of attention, executive function, and
verbal fluency.Serum NMDAR autoantibodies are associated
with isolated memory deficits in patients with cancer and
might serve as a potential biomarker for cancer-related
cognitive impairment.},
keywords = {Humans / Female / Male / Autoantibodies: blood / Middle
Aged / Receptors, N-Methyl-D-Aspartate: immunology / Aged /
Cross-Sectional Studies / Case-Control Studies / Adult /
Memory Disorders: blood / Memory Disorders: immunology /
Memory Disorders: etiology / Neoplasms: blood / Neoplasms:
complications / Neoplasms: immunology / Neoplasms:
psychology / Aged, 80 and over / Neuropsychological Tests /
Autoantibodies (NLM Chemicals) / Receptors,
N-Methyl-D-Aspartate (NLM Chemicals)},
cin = {AG Prüß},
ddc = {610},
cid = {I:(DE-2719)1810003},
pnm = {353 - Clinical and Health Care Research (POF4-353)},
pid = {G:(DE-HGF)POF4-353},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:41453122},
doi = {10.1212/WNL.0000000000214490},
url = {https://pub.dzne.de/record/283051},
}